J. B. Chemicals & Pharmaceuticals Limited Share Price

Equities

JBCHEPHARM

INE572A01036

Pharmaceuticals

Delayed Bombay S.E. 12:40:26 30/04/2024 pm IST 5-day change 1st Jan Change
1,896 INR -0.54% Intraday chart for J. B. Chemicals & Pharmaceuticals Limited +6.31% +16.72%
Sales 2024 * 35.01B 419M Sales 2025 * 40.58B 486M Capitalization 296B 3.54B
Net income 2024 * 5.64B 67.54M Net income 2025 * 7.06B 84.57M EV / Sales 2024 * 8.49 x
Net Debt 2024 * 1.32B 15.79M Net cash position 2025 * 4.41B 52.86M EV / Sales 2025 * 7.18 x
P/E ratio 2024 *
49.5 x
P/E ratio 2025 *
39.6 x
Employees 5,095
Yield 2024 *
0.64%
Yield 2025 *
0.75%
Free-Float 45.82%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on J. B. Chemicals & Pharmaceuticals Limited

1 day-0.54%
1 week+6.31%
Current month+14.95%
1 month+12.37%
3 months+14.82%
6 months+36.28%
Current year+16.72%
More quotes
1 week
1 779.40
Extreme 1779.4
1 919.10
1 month
1 652.55
Extreme 1652.55
1 919.10
Current year
1 473.95
Extreme 1473.95
1 935.00
1 year
914.65
Extreme 914.65
1 935.00
3 years
669.53
Extreme 669.525
1 935.00
5 years
153.50
Extreme 153.5
1 935.00
10 years
68.33
Extreme 68.325
1 935.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 05/20/05
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 59 31/20/31
Director/Board Member 40 07/11
Director/Board Member 48 10/21/10
More insiders
Date Price Change Volume
30/24/30 1,896 -0.54% 1 699
29/24/29 1,906 +2.27% 2,921
26/24/26 1,864 +0.48% 973
25/24/25 1,855 +1.69% 7,046
24/24/24 1,824 +2.30% 4,047

Delayed Quote Bombay S.E., April 30, 2024 at 12:40 pm IST

More quotes
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,906 INR
Average target price
1,882 INR
Spread / Average Target
-1.29%
Consensus
  1. Stock Market
  2. Equities
  3. JBCHEPHARM Stock